Camelia Quek

5PUBLICATIONS
98CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTumour immunologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 27, 2025
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma.

Georgina V Long, Elena Shklovskaya, Laveniya Satgunaseelan

|Nov 28, 2024
Cancer cells impair monocyte-mediated T cell stimulation to evade immunity.

Anais Elewaut, Guillem Estivill, Felix Bayerl

|Apr 08, 2024
Stroma-infiltrating T cell spatiotypes define immunotherapy outcomes in adolescent and young adult patients with melanoma.

Xinyu Bai, Grace H Attrill, Tuba N Gide

|Feb 15, 2023
Intratumoral CD16+ Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy.

Hansol Lee, Angela L Ferguson, Camelia Quek

|Sep 27, 2022
Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma.

Andrew W Hahn, Ashley V Menk, Dayana B Rivadeneira

Pageof 1

Frequent Collaborators

4 joint publications

Richard A Scolyer

4 joint publications

Georgina V Long

2 joint publications

James S Wilmott

2 joint publications

Elena Shklovskaya